U.S. flag

An official website of the United States government

NM_000406.3(GNRHR):c.784C>T (p.Arg262Trp) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 7, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003061549.3

Allele description [Variation Report for NM_000406.3(GNRHR):c.784C>T (p.Arg262Trp)]

NM_000406.3(GNRHR):c.784C>T (p.Arg262Trp)

Gene:
GNRHR:gonadotropin releasing hormone receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q13.2
Genomic location:
Preferred name:
NM_000406.3(GNRHR):c.784C>T (p.Arg262Trp)
HGVS:
  • NC_000004.12:g.67740683G>A
  • NG_009293.1:g.20404C>T
  • NM_000406.3:c.784C>TMANE SELECT
  • NM_001012763.2:c.656C>T
  • NP_000397.1:p.Arg262Trp
  • NP_001012781.1:p.Thr219Met
  • NC_000004.11:g.68606401G>A
Protein change:
R262W
Molecular consequence:
  • NM_000406.3:c.784C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001012763.2:c.656C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003459947Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jul 7, 2023)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures.

Cassatella D, Howard SR, Acierno JS, Xu C, Papadakis GE, Santoni FA, Dwyer AA, Santini S, Sykiotis GP, Chambion C, Meylan J, Marino L, Favre L, Li J, Liu X, Zhang J, Bouloux PM, Geyter C, Paepe A, Dhillo WS, Ferrara JM, Hauschild M, et al.

Eur J Endocrinol. 2018 Apr;178(4):377-388. doi: 10.1530/EJE-17-0568. Epub 2018 Feb 1.

PubMed [citation]
PMID:
29419413
PMCID:
PMC5863472

A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor.

de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E.

N Engl J Med. 1997 Nov 27;337(22):1597-602. No abstract available.

PubMed [citation]
PMID:
9371856
See all PubMed Citations (9)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003459947.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 262 of the GNRHR protein (p.Arg262Trp). This variant is present in population databases (rs753280668, gnomAD 0.01%). This missense change has been observed in individual(s) with hypogonadotropic hypogonadism (PMID: 29419413; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 2151986). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GNRHR protein function. This variant disrupts the p.Arg262 amino acid residue in GNRHR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9371856, 9425890, 10022417, 10084584, 12574221, 16968799, 26207952). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024